A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 267
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PBT
Long Form : proton beam therapy
No. Year Title Co-occurring Abbreviation
2019 A Literature Review of Proton Beam Therapy for Prostate Cancer in Japan. NHI
2019 A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer. IMRT, NTCP
2019 An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours. CTV, IMRT, LAD, LKB, NTCP, OARs, pts, PTV, SFUD
2019 Analysis of Gastrointestinal Toxicity in Patients Receiving Proton Beam Therapy for Prostate Cancer: A Single-Institution Experience. EPIC, GI, Gr, RB
2019 Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy. HCC, TACE, TAI
2019 Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer. IMPT, IMRT, NTCP, PSPT, RBE, TCP
2019 Breakdown of the blood-eye barrier in choroidal melanoma after proton beam radiotherapy. LFP
2019 Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies. ECOG, EQD2, OS, PFS
2019 Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies. ASTRO, IMRT, MPs, SABR, SRS
10  2019 Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting. GI, GU, IMRT, PC, TFS
11  2019 Consensus Report From the Miami Liver Proton Therapy Conference. ---
12  2019 Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients With Uveal Melanoma Treated With Proton Beam Therapy. DVH, RBE
13  2019 Defining Clinical Indications of Proton Beam Therapy at National Level in the Kingdom of Saudi Arabia. CNS, GRADE, KSA, SPTC
14  2019 Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours. AUC, NTCP
15  2019 Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma? BCLC, GyE, HCC, LRFS, mUICC, OS, PTV1
16  2019 Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis. CTCAE, GI, GU, IMRT, OARs, PCa, QOL, RT
17  2019 Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer. CRT, FARE, RBE
18  2019 Hypofractionated particle beam therapy for hepatocellular carcinoma-a brief review of clinical effectiveness. CIRT, CPT, HCC
19  2019 Hypofractionated proton beam therapy for centrally located lung cancer. OS, PFS
20  2019 Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy. HR, IMRT, LGG, PsP, RT
21  2019 Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment. PA
22  2019 Intraspinal Dissemination and Local Recurrence of an Intracranial Hemangiopericytoma. HPCs, PET, RT, SRS
23  2019 Maintenance of multidomain neurocognitive functions in pediatric patients after proton beam therapy: A prospective case-series study. NCF
24  2019 Model-based cost-effectiveness analysis of external beam radiation therapy for the treatment of localized prostate cancer: a systematic review. IMRT, NHS EED, PRISMA, SBRT
25  2019 Patient Transfer to Receive Proton Beam Therapy During Intensive Multimodal Therapy is Safe and Feasible for Patients With Newly Diagnosed High-risk Neuroblastoma. NB
26  2019 Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma. COG, HR, LC, OS, PFS
27  2019 Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. CHT, CPM, HR, ICE, LC, LF, RMS, RT
28  2019 Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy. HCC, LV, RILD, SLV, ULV
29  2019 Proton Beam Therapy Combined with Intra-Arterial Infusion Chemotherapy for Stage IV Adenoid Cystic Carcinoma of the Base of the Tongue. ACC, IAIC
30  2019 Proton Beam Therapy for Adolescent Primary Central Nervous System Lymphoma With Residual Tumor After Intensive Chemotherapy: A Case Report. PCNSL
31  2019 Proton Beam Therapy for Ameloblastic Carcinoma of the Maxilla: Report of a Rare Case. AC
32  2019 Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan. BED, NSCLC, OS, PFS
33  2019 Proton beam therapy for recurrent ovarian carcinoma: A case report. ---
34  2019 Proton beam therapy for renal pelvis and ureter cancer: A report of 5 cases and a literature review. RBE, RT
35  2019 Proton beam therapy in pediatric oncology. ---
36  2019 Proton beam therapy is a safe and feasible treatment for patients with second primary lung cancer after lung resection. ---
37  2019 Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. BED, HCC, OS
38  2019 Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis. BMI, IMN, LFRS, OS, PCG, re-RT
39  2019 Pseudoprogression after radiation therapies for low grade glioma in children and adults: A systematic review and meta-analysis. IMRT, PsP, RT
40  2019 Reirradiation of recurrent breast cancer with proton beam therapy: A case report and literature review. ---
41  2019 Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy. QOL, RCTs
42  2019 The Art of Living With Symptoms: A Qualitative Study Among Patients With Primary Brain Tumors Receiving Proton Beam Therapy. ---
43  2019 The Radiobiological Effects of Proton Beam Therapy: Impact on DNA Damage and Repair. CDD, LET
44  2018 A Dosimetric Comparison of Breast Radiotherapy Techniques to Treat Locoregional Lymph Nodes Including the Internal Mammary Chain. FB, IMC, OARs, vDIBH, VMAT, WT
45  2018 A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma. CTVs, HCC, QA
46  2018 Advanced Proton Beam Dosimetry Part I: review and performance evaluation of dose calculation algorithms. MC, PB, TPS
47  2018 Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy. NTCP, RILD, XRT
48  2018 Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies. CW, CWT, HR
49  2018 Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea. MRI
50  2018 Cost effectiveness of prostate cancer radiotherapy. DFS, IMRT
51  2018 Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma. HPV, ICERs, IMRT, OPC, PP, QALY
52  2018 Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors. PTV, SABR
53  2018 Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma. 3D-CRT, ESCC, IMRT
54  2018 Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes. EPIC, IPSS, SHIM
55  2018 Finding Value for Protons: The Case of Prostate Cancer? IMRT
56  2018 How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver. eSLV, GyE, HCC, NILV, NLV, RILD, rV30
57  2018 Hydrogel Nanosensors for Colorimetric Detection and Dosimetry in Proton Beam Radiotherapy. ---
58  2018 Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma. ALBI, CTCAE, HCC, mRECIST
59  2018 Insurance coverage decisions for pediatric proton therapy. ---
60  2018 Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors. ESFT, VDC-IE
61  2018 Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer. NSCLC
62  2018 Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation. IMRT, OR
63  2018 Mathematical Modelling for Patient Selection in Proton Therapy. ---
64  2018 Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial. GI, GU
65  2018 Normal liver tissue change after proton beam therapy. ---
66  2018 Occurrence of Phosphenes in Patients Undergoing Proton Beam Therapy for Ocular Tumor. ---
67  2018 Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma. CR, HCC, LPFS, RFS
68  2018 Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy. ---
69  2018 Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system. ---
70  2018 Proton Beam Therapy - the Challenges of Delivering High-quality Evidence of Clinical Benefit. ---
71  2018 Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study. ADT, fr, PCa
72  2018 Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma. CIRT
73  2018 Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer. NSCLC, RT
74  2018 Proton beam therapy for cancer in the era of precision medicine. ---
75  2018 Proton beam therapy for gastrointestinal cancers: past, present, and future. GI
76  2018 Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature. HCC
77  2018 Proton Beam Therapy without Fiducial Markers Using Four-Dimensional CT Planning for Large Hepatocellular Carcinomas. CGE, HCC, ITV, LTC, OS, PFS
78  2018 Proton Therapy for Craniopharyngioma - An Early Report from a Single European Centre. ---
79  2018 Proton therapy for early-stage non-small cell lung cancer (NSCLC). IGRT, IMPT, NSCLC, SABR
80  2018 Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives. HCC, RT
81  2018 Proton therapy for pediatric head and neck malignancies. RBE
82  2018 Proton therapy for small cell lung cancer. LS-SCLC, NSCLC, RT
83  2018 Proton Therapy in Non-small Cell Lung Cancer. NSCLC
84  2018 Range optimization for target and organs at risk in dynamic adaptive passive scattering proton beam therapy - A proof of concept. BR, OARs, OP, RO-T, RO-TO, TR
85  2018 Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma. HN-ARMS
86  2018 Respiratory-gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers. CGE, HCC
87  2018 Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. EC, IMRT, nCRT
88  2018 Simulation study of dosimetric effect in proton beam therapy using concomitant boost technique for unresectable pancreatic cancers. GI, GyE
89  2018 Successful Endoscopic Closure Using Polyglycolic Acid Sheets with Fibrin Glue for Nonhealing Duodenal Ulcer with Perforation after Proton Beam Therapy of Liver Tumor. EGD, PGA
90  2018 The evolution of proton beam therapy: Current and future status. ---
91  2018 The expanding role of radiation therapy for thymic malignancies. IMRT, LC, OARs, PORT, RT
92  2018 The role of proton beam therapy in central neurocytoma: A single-institution experience. CNs, PFS
93  2018 Toward A variable RBE for proton beam therapy. RBE
94  2018 Utilization of neoadjuvant intensity-modulated radiation therapy and proton beam therapy for esophageal cancer in the United States. EC, IMRT, NCDB, OS, RT
95  2018 What Conditions Make Proton Beam Therapy Financially Viable in Western Canada? RT
96  2017 A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors. 3DCRT, IMRT
97  2017 A feasibility study of a hybrid breast-immobilization system for early breast cancer in proton beam therapy. EBC, WBIS
98  2017 A retrospective study of late adverse events in proton beam therapy for prostate cancer. CAB, PSA
99  2017 An unexpected skin ulcer and soft tissue necrosis after the nonconcurrent combination of proton beam therapy and pazopanib: A case of myxofibrosarcoma. MFS
100  2017 Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma. OS, RILD